Typing TPMT and ITPase to detect azathioprine toxicity

被引:6
作者
Arenas, Monica
Marinaki, Anthony
Ansari, Azhar
Sanderson, Jeremy
机构
[1] St Thomas Hosp, Guys & St Thomas Hosp, Dept Gastroenterol, London SE1 7EH, England
[2] Guys Hosp, Purine Res Lab, London SE1 9RT, England
关键词
6-mercaptopurine; adverse effects; azathioprine; drug toxicity; inflammatory bowel disease; inosine triphosphatase; inosine triphosphate; pyrophosphohydrolase; ITPA; ITPase; thiopurine methyl transferase; thiopurine; TPMT;
D O I
10.2217/17410541.3.1.45
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Genetic variation in thiopurine methyltransferase (TPMT) enzyme activity strongly predicts adverse effects in patients treated with the thiopurine drugs, azathioprine and 6-mercaptopurine, and is one of the classic examples of pharmacogenetics in clinical practice. Recently, polymorphic variation in the gene encoding the enzyme inosine triphosphatase (ITPase) has also been associated with risk of thiopurine-related toxicity. This article reviews the evidence for the role of TPMT and ITPase deficiency as predictors of thiopurine toxicity and makes recommendations for clinical and laboratory practice.
引用
收藏
页码:45 / 59
页数:15
相关论文
共 110 条
[51]   Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease [J].
Kirschner, BS .
GASTROENTEROLOGY, 1998, 115 (04) :813-821
[52]   A SINGLE-POINT MUTATION LEADING TO LOSS OF CATALYTIC ACTIVITY IN HUMAN THIOPURINE S-METHYLTRANSFERASE [J].
KRYNETSKI, EY ;
SCHUETZ, JD ;
GALPIN, AJ ;
PUI, CH ;
RELLING, MV ;
EVANS, WE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (04) :949-953
[53]   Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus [J].
Kubota, T ;
Chiba, K .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (05) :475-477
[54]   Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese [J].
Kumagai, K ;
Hiyama, K ;
Ishioka, S ;
Sato, H ;
Yamanishhi, Y ;
McLeod, HL ;
Konishi, F ;
Maeda, H ;
Yamakido, M .
PHARMACOGENETICS, 2001, 11 (03) :275-278
[55]   Severe azathioprine-induced mye otoxicity in a kidney transplant patient with thiopurine S-methyltransferasedeficient genotype (TPMT*3A/*3C) [J].
Kurzawski, M ;
Dziewanowski, K ;
Ciechanowski, K ;
Drozdzik, M .
TRANSPLANT INTERNATIONAL, 2005, 18 (05) :623-625
[56]   Frequency distribution of thiopurine S-methyltransferase alleles in a Polish population [J].
Kurzawski, M ;
Gawronska-Szklarz, B ;
Drozdzik, M .
THERAPEUTIC DRUG MONITORING, 2004, 26 (05) :541-545
[57]   Genetic polymorphism of thiopurine S-methyltransferase in Argentina [J].
Laróvere, LE ;
de Kremer, RD ;
Lambooy, LHJ ;
De Abreu, RA .
ANNALS OF CLINICAL BIOCHEMISTRY, 2003, 40 :388-393
[58]   Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis [J].
Leipold, G ;
Schutz, E ;
Haas, JP ;
Oellerich, M .
ARTHRITIS AND RHEUMATISM, 1997, 40 (10) :1896-1898
[59]   GENETIC-VARIATION IN RESPONSE TO 6-MERCAPTOPURINE FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
LENNARD, L ;
LILLEYMAN, JS ;
VANLOON, J ;
WEINSHILBOUM, RM .
LANCET, 1990, 336 (8709) :225-229
[60]   MERCAPTOPURINE METABOLISM AND RISK OF RELAPSE IN CHILDHOOD LYMPHOBLASTIC-LEUKEMIA [J].
LILLEYMAN, JS ;
LENNARD, L .
LANCET, 1994, 343 (8907) :1188-1190